Category: Biotechnology
Biotechnology market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Cerus Corporation (CERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cerus Corporation (CERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Cerus Corporation (CERS:NAS). Includes Industry Averages & Top C ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Agenus Inc (AGEN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Agenus Inc (AGEN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Agenus Inc (AGEN:NAS). Includes Industry Averages & Top Competitors, KP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Av ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kane Biotech Inc (KNE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kane Biotech Inc (KNE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Kane Biotech Inc (KNE:TSX). Includes Industry Averages & Top Compe ... Read More
-
Financial Analysis and Multi-Year Benchmarking: BioMark Diagnostics Inc (BUX:CNQ). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: BioMark Diagnostics Inc (BUX:CNQ). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: BioMark Diagnostics Inc (BUX:CNQ). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Edesa Biotech Inc (EDSA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Edesa Biotech Inc (EDSA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Edesa Biotech Inc (EDSA:NAS). Includes Industry Averages & Top C ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199 Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fra ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.) ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Nektar Therapeutics (NKTR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Nektar Therapeutics (NKTR:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Nektar Therapeutics (NKTR:NAS). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ImmuCell Corporation (ICCC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ImmuCell Corporation (ICCC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: ImmuCell Corporation (ICCC:NAS). Includes Industry Averages & ... Read More
-
Plunkett's Health Care Industry Almanac 2025: Health Care Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S HEALTH CARE INDUSTRY ALMANAC 2025 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Health Care Industry. Gain vital insights that can help shape strategy for business developme ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2025 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights tha ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414 Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmark ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412 Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Ben ... Read More
-
Basic Organic Chemical Manufacturing, Including Petrochemical Intermediates, Silicone, Ethanol, Plasticizers and Enzyme Proteins (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325190
Basic Organic Chemical Manufacturing, Including Petrochemical Intermediates, Silicone, Ethanol, Plasticizers and Enzyme Proteins (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325190 Basic Organic Chemical Manufacturing, Including Petrochemical Interme ... Read More
-
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710 Scientific Research and Development (R&D) in Physics, Engineering, Life Sc ... Read More
-
Miromatrix Medical Inc (MIRO:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Miromatrix Medical Inc (MIRO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Miromatrix Medical Inc (MIRO:NAS) compared to its top competitors and compared ... Read More
-
Caribou Biosciences Inc (CRBU:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Caribou Biosciences Inc (CRBU:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Caribou Biosciences Inc (CRBU:NAS) compared to its top competitors and compar ... Read More
-
Natera Inc (NTRA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Natera Inc (NTRA:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Charles River Laboratories International Inc (CRL:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Charles River Laboratories International Inc (CRL:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Charles River Laboratories International Inc (CRL:NYS) co ... Read More
-
Agilent Technologies Inc (A:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Agilent Technologies Inc (A:NYS) compared to its top competitors and compared t ... Read More
-
908 Devices Inc (MASS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
908 Devices Inc (MASS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for 908 Devices Inc (MASS:NAS) compared to its top competitors and compared to the averag ... Read More
-
Regeneron Pharmaceuticals Inc (REGN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Regeneron Pharmaceuticals Inc (REGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Regeneron Pharmaceuticals Inc (REGN:NAS) compared to its top competitor ... Read More
Research Assistance
